Nov 11, 2025 11:50PM

Nov 11, 2025 11:50PM

Mar 27, 2025 10:30PM

Mar 24, 2025 02:30AM

Apr 19, 2023 05:09PM

Mar 7, 2023 04:35PM

Mar 7, 2023 04:30PM DBV Technologies Announces First Patient Screened in VITESSE Phase 3 Clinical Trial in Peanut-Allergic Children 4 – 7 Years Old

Dec 23, 2022 01:30AM

Nov 9, 2022 01:30AM

Nov 3, 2022 04:30PM

Sep 21, 2022 05:45PM

Sep 7, 2022 04:30PM

Aug 10, 2022 04:50PM

Aug 1, 2022 04:30PM DBV Technologies Reports Second Quarter 2022 Financial Results

Jun 28, 2022 06:15PM

Jun 7, 2022 04:30PM

Jun 7, 2022 04:30PM

May 2, 2022 04:00PM

Mar 3, 2022 04:15PM

Dec 20, 2021 04:15PM

Oct 26, 2021 04:15PM DBV Technologies Reports Third Quarter 2021 Financial Results and Recent Regulatory Developments

Aug 2, 2021 04:15PM

Mar 11, 2021 04:30PM

Feb 22, 2021 01:30AM

Jan 14, 2021 04:31PM

Jan 14, 2021 04:30PM

Nov 2, 2020 08:41AM

Nov 2, 2020 01:30AM DBV Technologies Announces Filing and Validation of Marketing Authorization Application for Viaskin™ Peanut by European Medicines Agency 

Oct 30, 2020 02:30AM

Sep 9, 2020 01:30AM

Aug 4, 2020 01:30AM

Jul 31, 2020 01:30AM

Jul 10, 2020 09:00AM

Jun 26, 2020 09:16AM

Jun 26, 2020 02:30AM DBV Technologies Provides Operational and Business Update

Jun 4, 2020 04:30PM

Mar 16, 2020 04:32PM

Mar 16, 2020 04:30PM

Mar 4, 2020 04:30PM

Feb 21, 2020 09:29AM

Jan 8, 2020 04:31PM

Jan 8, 2020 04:30PM DBV Technologies Reports Positive Three-Year, Long-Term Data from the PEOPLE Phase III Open-Label Extension Study of Viaskin Peanut in Children with Peanut Allergy

Oct 24, 2019 04:01PM

Oct 4, 2019 11:46AM

Oct 4, 2019 11:45AM

Aug 7, 2019 05:28PM

Aug 7, 2019 04:05PM

Aug 1, 2019 01:30AM

Jun 26, 2019 01:30AM DBV Technologies Announces Appointment of Pharis Mohideen, M.D., as Chief Medical Officer  

Mar 5, 2019 11:10AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All